Cargando…
Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer
Purpose: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have been...
Autores principales: | Domvri, Kalliopi, Zarogoulidis, Konstantinos, Zogas, Nikolaos, Zarogoulidis, Paul, Petanidis, Savvas, Porpodis, Konstantinos, Kioseoglou, Efrosini, Hohenforst-Schmidt, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688917/ https://www.ncbi.nlm.nih.gov/pubmed/29151951 http://dx.doi.org/10.7150/jca.21783 |
Ejemplares similares
-
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
por: Zarogoulidis, Paul, et al.
Publicado: (2012) -
Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation
por: Domvri, Kalliopi, et al.
Publicado: (2020) -
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8(+)T Cell Immunity
por: Domvri, Kalliopi, et al.
Publicado: (2022) -
Zarogouldis, P., et al., Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology. Int. J. Mol. Sci. 2012, 13, 10828–10862
por: Zarogoulidis, Paul, et al.
Publicado: (2012) -
Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
por: Porpodis, Konstantinos, et al.
Publicado: (2015)